Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Published under a CC BY-NC license

Erratum to ms. HAEMATOL/2020/278258. “Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-kB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation” Haematologica. 2021 Oct 1;106(10):2749-2753. doi: 10.3324/haema-tol.2020.278258. PMID: 33979991; PMCID: PMC8485659.

Gaël Roué, as corresponding author of the above-referenced article, declares that the request for an addition of a new affiliation for one of the authors (M. Armengol) has been approved by all co-authors. This modification is a prerequisite of Barcelona Autonomous University’s Doctorate program to enable the inclusion of this work in the doctoral thesis of M. Armengol.